<MedlineCitation Status="Completed">
<MedlineID>10011877</MedlineID>
<PMID>421146</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-8993</ISSN>
<JournalIssue>
<Volume>165</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1979</Year>
<Month>Apr</Month>
<Day>13</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Evidence suggesting secondary epileptogenic lesion after kainic acid: pre treatment with diazepam reduces distant but not local brain damage.</ArticleTitle>
<Pagination>
<MedlinePgn>362-5</MedlinePgn>
</Pagination>
<AuthorList>
<Author>
<LastName>Ben-Ari</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author>
<LastName>Tremblay</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author>
<LastName>Ottersen</LastName>
<ForeName>O P</ForeName>
<Initials>OP</Initials>
</Author>
<Author>
<LastName>Naquet</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Brain Res</MedlineTA>
<NlmUniqueID>0045503</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Pyrrolidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>439-14-5</RegistryNumber>
<NameOfSubstance>Diazepam</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>487-79-6</RegistryNumber>
<NameOfSubstance>Kainic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Amygdala</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Convulsions</DescriptorName>
<QualifierName MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName>prevention &#38; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Diazepam</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Kainic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Nerve Degeneration</DescriptorName>
<QualifierName>drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Neural Pathways</DescriptorName>
<QualifierName>drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Premedication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Pyrrolidines</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Rats</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
